These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 21534606)

  • 1. Quercetin diacylglycoside analogues showing dual inhibition of DNA gyrase and topoisomerase IV as novel antibacterial agents.
    Hossion AM; Zamami Y; Kandahary RK; Tsuchiya T; Ogawa W; Iwado A; Sasaki K
    J Med Chem; 2011 Jun; 54(11):3686-703. PubMed ID: 21534606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3-aminoquinazolinediones as a new class of antibacterial agents demonstrating excellent antibacterial activity against wild-type and multidrug resistant organisms.
    Ellsworth EL; Tran TP; Showalter HD; Sanchez JP; Watson BM; Stier MA; Domagala JM; Gracheck SJ; Joannides ET; Shapiro MA; Dunham SA; Hanna DL; Huband MD; Gage JW; Bronstein JC; Liu JY; Nguyen DQ; Singh R
    J Med Chem; 2006 Nov; 49(22):6435-8. PubMed ID: 17064062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis and structure-activity relationship studies of novel indazole analogues as DNA gyrase inhibitors with Gram-positive antibacterial activity.
    Tanitame A; Oyamada Y; Ofuji K; Kyoya Y; Suzuki K; Ito H; Kawasaki M; Nagai K; Wachi M; Yamagishi J
    Bioorg Med Chem Lett; 2004 Jun; 14(11):2857-62. PubMed ID: 15125947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel topoisomerase inhibitors: microbiological characterisation and in vivo efficacy of pyrimidines.
    Uria-Nickelsen M; Neckermann G; Sriram S; Andrews B; Manchester JI; Carcanague D; Stokes S; Hull KG
    Int J Antimicrob Agents; 2013 Apr; 41(4):363-71. PubMed ID: 23305654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel dual-targeting benzimidazole urea inhibitors of DNA gyrase and topoisomerase IV possessing potent antibacterial activity: intelligent design and evolution through the judicious use of structure-guided design and structure-activity relationships.
    Charifson PS; Grillot AL; Grossman TH; Parsons JD; Badia M; Bellon S; Deininger DD; Drumm JE; Gross CH; LeTiran A; Liao Y; Mani N; Nicolau DP; Perola E; Ronkin S; Shannon D; Swenson LL; Tang Q; Tessier PR; Tian SK; Trudeau M; Wang T; Wei Y; Zhang H; Stamos D
    J Med Chem; 2008 Sep; 51(17):5243-63. PubMed ID: 18690678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potent DNA gyrase inhibitors; novel 5-vinylpyrazole analogues with Gram-positive antibacterial activity.
    Tanitame A; Oyamada Y; Ofuji K; Suzuki K; Ito H; Kawasaki M; Wachi M; Yamagishi J
    Bioorg Med Chem Lett; 2004 Jun; 14(11):2863-6. PubMed ID: 15125948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel DNA gyrase inhibitors: microbiological characterisation of pyrrolamides.
    Uria-Nickelsen M; Blodgett A; Kamp H; Eakin A; Sherer B; Green O
    Int J Antimicrob Agents; 2013 Jan; 41(1):28-35. PubMed ID: 23142086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isothiazolopyridones: synthesis, structure, and biological activity of a new class of antibacterial agents.
    Wiles JA; Hashimoto A; Thanassi JA; Cheng J; Incarvito CD; Deshpande M; Pucci MJ; Bradbury BJ
    J Med Chem; 2006 Jan; 49(1):39-42. PubMed ID: 16392790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploration of the activity of 7-pyrrolidino-8-methoxyisothiazoloquinolones against methicillin-resistant Staphylococcus aureus (MRSA).
    Kim HY; Wiles JA; Wang Q; Pais GC; Lucien E; Hashimoto A; Nelson DM; Thanassi JA; Podos SD; Deshpande M; Pucci MJ; Bradbury BJ
    J Med Chem; 2011 May; 54(9):3268-82. PubMed ID: 21425851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, and biological evaluation of a novel series of quercetin diacylglucosides as potent anti-MRSA and anti-VRE agents.
    Hossion AM; Otsuka N; Kandahary RK; Tsuchiya T; Ogawa W; Iwado A; Zamami Y; Sasaki K
    Bioorg Med Chem Lett; 2010 Sep; 20(17):5349-52. PubMed ID: 20655215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and structure-activity relationships of 2-pyridones: a novel series of potent DNA gyrase inhibitors as antibacterial agents.
    Li Q; Chu DT; Claiborne A; Cooper CS; Lee CM; Raye K; Berst KB; Donner P; Wang W; Hasvold L; Fung A; Ma Z; Tufano M; Flamm R; Shen LL; Baranowski J; Nilius A; Alder J; Meulbroek J; Marsh K; Crowell D; Hui Y; Seif L; Melcher LM; Plattner JJ
    J Med Chem; 1996 Aug; 39(16):3070-88. PubMed ID: 8759628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and antibacterial activity of novel and potent DNA gyrase inhibitors with azole ring.
    Tanitame A; Oyamada Y; Ofuji K; Fujimoto M; Suzuki K; Ueda T; Terauchi H; Kawasaki M; Nagai K; Wachi M; Yamagishi J
    Bioorg Med Chem; 2004 Nov; 12(21):5515-24. PubMed ID: 15465328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis, and evaluation of novel fluoroquinolone-aminoglycoside hybrid antibiotics.
    Pokrovskaya V; Belakhov V; Hainrichson M; Yaron S; Baasov T
    J Med Chem; 2009 Apr; 52(8):2243-54. PubMed ID: 19301822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and antibacterial activity of a novel series of potent DNA gyrase inhibitors. Pyrazole derivatives.
    Tanitame A; Oyamada Y; Ofuji K; Fujimoto M; Iwai N; Hiyama Y; Suzuki K; Ito H; Terauchi H; Kawasaki M; Nagai K; Wachi M; Yamagishi J
    J Med Chem; 2004 Jul; 47(14):3693-6. PubMed ID: 15214796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and structure-activity relationship studies of 4-arylthiosemicarbazides as topoisomerase IV inhibitors with Gram-positive antibacterial activity. Search for molecular basis of antibacterial activity of thiosemicarbazides.
    Siwek A; Stączek P; Stefańska J
    Eur J Med Chem; 2011 Nov; 46(11):5717-26. PubMed ID: 21978836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, and characterization of novel tetrahydropyran-based bacterial topoisomerase inhibitors with potent anti-gram-positive activity.
    Surivet JP; Zumbrunn C; Rueedi G; Hubschwerlen C; Bur D; Bruyère T; Locher H; Ritz D; Keck W; Seiler P; Kohl C; Gauvin JC; Mirre A; Kaegi V; Dos Santos M; Gaertner M; Delers J; Enderlin-Paput M; Boehme M
    J Med Chem; 2013 Sep; 56(18):7396-415. PubMed ID: 23968485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of a novel azaindole class of antibacterial agents targeting the ATPase domains of DNA gyrase and Topoisomerase IV.
    Manchester JI; Dussault DD; Rose JA; Boriack-Sjodin PA; Uria-Nickelsen M; Ioannidis G; Bist S; Fleming P; Hull KG
    Bioorg Med Chem Lett; 2012 Aug; 22(15):5150-6. PubMed ID: 22814212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of nemonoxacin (TG-873870), a novel non-fluorinated quinolone, against clinical isolates of Staphylococcus aureus, enterococci and Streptococcus pneumoniae with various resistance phenotypes in Taiwan.
    Chen YH; Liu CY; Lu JJ; King CH; Hsueh PR
    J Antimicrob Chemother; 2009 Dec; 64(6):1226-9. PubMed ID: 19833635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of (3S)-amino-(4R)-ethylpiperidinyl quinolones as potent antibacterial agents with a broad spectrum of activity and activity against resistant pathogens.
    Hu XE; Kim NK; Gray JL; Almstead JI; Seibel WL; Ledoussal B
    J Med Chem; 2003 Aug; 46(17):3655-61. PubMed ID: 12904069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An optimised series of substituted N-phenylpyrrolamides as DNA gyrase B inhibitors.
    Tiz DB; Skok Ž; Durcik M; Tomašič T; Mašič LP; Ilaš J; Zega A; Draskovits G; Révész T; Nyerges Á; Pál C; Cruz CD; Tammela P; Žigon D; Kikelj D; Zidar N
    Eur J Med Chem; 2019 Apr; 167():269-290. PubMed ID: 30776691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.